Check Out What Whales Are Doing With VKTX
Portfolio Pulse from Benzinga Insights
Whales show a bullish stance on Viking Therapeutics (NASDAQ:VKTX), with significant options trading activity indicating a price target range of $20 to $120. The majority of trades are calls, suggesting optimism about the stock's future performance. Viking Therapeutics specializes in biopharmaceutical development for metabolic and endocrine disorders. The stock is currently up 0.74% at $75.97, with an RSI indicating it may be approaching overbought territory. Analysts have set an average target price of $90, with a recent downgrade to Buy by HC Wainwright & Co.
April 30, 2024 | 2:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Viking Therapeutics shows bullish signals from whales with a price target range of $20-$120. The stock is up 0.74% at $75.97, but RSI may indicate overbought conditions. Analyst consensus targets $90, with a recent downgrade to Buy.
The bullish stance by whales, combined with the current stock performance and analyst ratings, suggests a positive short-term outlook for VKTX. However, the RSI indicator and the recent downgrade to Buy introduce caution.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100